自噬
免疫原性细胞死亡
免疫系统
光热治疗
癌症研究
免疫疗法
程序性细胞死亡
抗原
药理学
化学
免疫学
医学
细胞凋亡
材料科学
生物化学
纳米技术
作者
Na Tu,Xue Shen,Shengqi Deng,Yuxin Xie,Haowei Liu,Hongping Li,Nan Li,Ling Mei
标识
DOI:10.1021/acsanm.3c04532
摘要
In the past decade, tumor treatment strategies have shifted from tumors to the immune system of tumor patients. NIR laser-induced photothermal therapy can not only generate heat or reactive oxygen species to kill tumors but also induce immunogenic cell death and activate the overall antitumor immune response. The ICD process is usually accompanied by autophagosome formation, which contains tumor-associated antigens. However, the fusion of autophagosome and lysosome impairs antigens, weakening the antitumor immune response. Thus, administration with autophagy terminal inhibitors could be a compensatory strategy. In this work, we prepared a thermally sensitive liposome drug delivery system containing the photothermal agent IR780 and autophagy inhibitor HCQ (IR780/HCQ-Lip). IR780/HCQ-Lip has a uniform particle size distribution and good photodynamic and photothermal properties. The inhibition of autophagy enhanced the phototherapy effect. Compared with the survival rate of 4T1 cells being treated with IR780-Lip phototherapy alone (36.87%), the survival rate of the IR780/HCQ-Lip group decreased to 3.71%. IR780/HCQ-Lip caused a massive accumulation of autophagosomes, promoted the maturation of dendritic cells (DCs), and enhanced the infiltration of intratumoral T cells. In addition, IR780/HCQ-Lip produced a systemic immune response and also showed good inhibition of distal tumor growth under laser action in distal tumor experiments. Thus, IR780/HCQ-Lip exhibited a promising combination therapy for the treatment of breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI